Your browser doesn't support javascript.
loading
Characterization of FcγRIIIA effector cells used in in vitro ADCC bioassay: Comparison of primary NK cells with engineered NK-92 and Jurkat T cells.
Hsieh, Yao-Te; Aggarwal, Poonam; Cirelli, David; Gu, Ling; Surowy, Teresa; Mozier, Ned M.
Afiliação
  • Hsieh YT; Analytical R&D, Biotherapeutics Pharm. Sci., Pfizer Inc., Chesterfield, MO, United States. Electronic address: yao-te.hsieh@pfizer.com.
  • Aggarwal P; Analytical R&D, Biotherapeutics Pharm. Sci., Pfizer Inc., Chesterfield, MO, United States. Electronic address: poonam.aggarwal@pfizer.com.
  • Cirelli D; Analytical R&D, Biotherapeutics Pharm. Sci., Pfizer Inc., Andover, MA, United States.
  • Gu L; Analytical R&D, Biotherapeutics Pharm. Sci., Pfizer Inc., Andover, MA, United States.
  • Surowy T; Analytical R&D, Biotherapeutics Pharm. Sci., Pfizer Inc., Chesterfield, MO, United States.
  • Mozier NM; Analytical R&D, Biotherapeutics Pharm. Sci., Pfizer Inc., Chesterfield, MO, United States.
J Immunol Methods ; 441: 56-66, 2017 02.
Article em En | MEDLINE | ID: mdl-27939300
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bioensaio / Células Matadoras Naturais / Receptores de IgG / Engenharia Celular / Citotoxicidade Celular Dependente de Anticorpos Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bioensaio / Células Matadoras Naturais / Receptores de IgG / Engenharia Celular / Citotoxicidade Celular Dependente de Anticorpos Idioma: En Ano de publicação: 2017 Tipo de documento: Article